Boyd Haley

Boyd E Haley, PhD, is the Chief Executive Officer of EmeraMed Limited, a biotechnology company engaged in the process of submitting its technology for drug approval since 2005. Recognized as one of the world's leading experts on mercury and heavy metal toxicity, they have garnered millions in grant funding to advance knowledge in this critical field. Boyd previously served as Chairman of the Department of Chemistry and a professor at the University of Kentucky from 1996 to 2004, and as a professor at the University of Wyoming from 1974 to 1985. Boyd's academic credentials include a PhD in Chemistry/Biochemistry from Washington State University, an NIH Postdoctoral Scholar designation from Yale University, and degrees from the University of Idaho and Franklin College.